Vitamin c boost: new combo trial for bone marrow disease
NCT ID NCT07283900
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests whether adding high-dose vitamin C to a standard chemotherapy drug (azacitidine) can help adults with a bone marrow disorder called myelodysplastic syndrome (MDS). About 38 participants with higher-risk MDS will receive the combination intravenously. The goal is to see if the combo is safe and improves treatment response, such as achieving remission or reducing the need for blood transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.